---
document_datetime: 2023-09-21 17:10:26
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/quintanrix-epar-all-authorised-presentations_en.pdf
document_name: quintanrix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4568892
conversion_datetime: 2025-12-31 02:47:20.66917
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number                                                      | Invented namStrength                                           | Invented namStrength                                           | Pharmaceutical Form                                          | Route of administration        | Packaging                                                        | Content                        | Package size                   |
|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|--------------------------------------------------------------|--------------------------------|------------------------------------------------------------------|--------------------------------|--------------------------------|
| EU/1/4/301/001                                                 | Quintanrix                                                     | -- 1                                                           | Powder and suspension for suspension for                     | Intramuscular use              | powder: vial (glass); suspension:vial                            | 0.5 ml                         | 1 vial + 1 vial                |
| EU/1/4/301/002                                                 | Quintanrix                                                     | -- 1                                                           | injection Powder and suspension for suspension for           | Intramuscular use              | authorised (glass) powder: vial (glass); suspension:vial (glass) | 0.5 ml                         | 100 vials + 100 vials          |
| EU/1/4/301/003                                                 | Quintanrix                                                     | -- 1                                                           | injection Powder and suspension for suspension for injection | Intramuscular use              | longer powder: vial (glass); suspension:vial (glass)             | 1 ml                           | 1 vial + 1 vial                |
| EU/1/4/301/004                                                 | Quintanrix                                                     | -- 1                                                           | Powder and suspension for suspension for injection           | no Intramuscular use           | powder: vial (glass); suspension:vial                            | 1 ml                           | 100 vials + 100 vials          |
| EU/1/4/301/005                                                 | Quintanrix                                                     | -- 1                                                           | Product Powder and suspension for suspension for injection   | Intramuscular use              | (glass) powder: vial (glass); suspension:vial (glass)            | 5 ml                           | 50 vials + 50 vials            |
| -- 1 1 dose (0.5 ml) contains:                                 | -- 1 1 dose (0.5 ml) contains:                                 | -- 1 1 dose (0.5 ml) contains:                                 | -- 1 1 dose (0.5 ml) contains:                               | -- 1 1 dose (0.5 ml) contains: | -- 1 1 dose (0.5 ml) contains:                                   | -- 1 1 dose (0.5 ml) contains: | -- 1 1 dose (0.5 ml) contains: |
| Diphtheria toxoid*                                             | Diphtheria toxoid*                                             | Diphtheria toxoid*                                             | ≥ 30 IU                                                      | ≥ 30 IU                        | ≥ 30 IU                                                          | ≥ 30 IU                        | ≥ 30 IU                        |
| Tetanus toxoid*                                                | Tetanus toxoid*                                                | Tetanus toxoid*                                                | ≥ 60 IU                                                      | ≥ 60 IU                        | ≥ 60 IU                                                          | ≥ 60 IU                        | ≥ 60 IU                        |
| Medicinal Inactivated Bordetella pertussis strain**            | Medicinal Inactivated Bordetella pertussis strain**            | Medicinal Inactivated Bordetella pertussis strain**            | ≥ 4 IU                                                       | ≥ 4 IU                         | ≥ 4 IU                                                           | ≥ 4 IU                         | ≥ 4 IU                         |
| Hepatitis B virus surface antigen recombinant** (S protein)*** | Hepatitis B virus surface antigen recombinant** (S protein)*** | Hepatitis B virus surface antigen recombinant** (S protein)*** | 10 micrograms                                                | 10 micrograms                  | 10 micrograms                                                    | 10 micrograms                  | 10 micrograms                  |

<div style=\"page-break-after: always\"></div>

<!-- image -->